REFG Medical Cannabis Payment Solutions

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

A Big Leap for Physical AI Can't pretend I saw this coming—Ceva's making waves with Mobilint's new REGULUS edge AI SoC, aiming to flip the script on how we think about physical AI devices. This combo of Ceva's NeuPro NPU and SensPro AI DSP is more than just tech talk; it's a gutsy move that shows us edge devices might be the hunting ground for AI innovation. Sensors and...

Revolution or Just Better Options? In the wild west of internet connectivity, where every home is a frontier, ElektraFi is throwing down the gauntlet at the feet of behemoths like Starlink. They're talking big about their fixed wireless network, and in places stretching from Colorado's ski slopes to the dustier reaches of Texas, that talk might just hold some weight. Why...

If you’ve been watching the developments in the world of obesity treatments, Ascletis Pharma is a name you'd do well not to ignore. With ObesityWeek 2026 on the horizon, these folks aren’t just talking—they’re putting their preclinical cards on the table and they’re noteworthy. Unveiling Future Contenders Ascletis is gearing up to present some of their...

Big Wins for Small Operations: The Greenworks Gamble Here's something that'll make any grass-whisperer perk up. Greenworks® Commercial, known for their battery-centered machinery, juiced some serious goodwill at the Equip Exposition 2026. They coughed up nearly $34,000 in gear, dishing out prizes like really expensive candy at a lawn-care carnival. Lucky Draw Brings...

There's a badge of honor in the investment world that's not about the dollars and cents pouring in—it's about having founders trust you to take care of their business babies. Good Springs Capital just snagged one by being named to Inc.'s 2026 Founder-Friendly Investors list. Now, if you're thinking this is just some fancy accolade, let's chew over the real nuggets here....

Talk about pulling a rabbit out of the hat! Lazard has just solidified its position in the private capital advisory game with the closure of its acquisition of Campbell Lutyens. They’re now rolling out Lazard CL, merging muscle across different strategies and diversifying those good ol’ revenue streams. It’s a peppy move from Lazard—not just for the cold hard...

You know, the market's all abuzz with AI this, AI that. But today, we're getting a glimpse at something that isn't just hyped-up vaporware; it's actually useful. Clarivate Plc (NYSE:CLVT), which has carved a niche in transformative intelligence, is teaming up with Microsoft to slide their CompuMark trademark data into Microsoft Copilot via something they call IPOne. It's...

Diving into Investcorp's Robust 2026 Performance If you're clued into the investment scene, you'll know that a $65.2 billion asset base isn't small potatoes. At the Gateway Gulf 2026, Investcorp didn't just present numbers—they laid out a dramatic year of action packed with billion-dollar dreams. While the dust hasn't quite settled yet, the first nine months of the year...

Digging Deeper into Check Point's Latest Figures When Check Point Software Technologies Ltd. (NASDAQ:CHKP) throws numbers at the wall, not everything sticks, but there's always something telling. The Q3 financial results for 2026 are out, and it's a mixed bag—coffee’s getting cold before you parse through it. Revenue and Subscription Dynamics Let's cut to it: total...

Manufacturing’s Talent Challenges in the Era of Industry 5.0 As we transition from Industry 4.0 to Industry 5.0, the focus is shifting dramatically towards a more human-centric approach. This evolution presents a pressing challenge for manufacturers: a growing skills crisis in IT. Organizations now face the daunting task of not only acquiring technology but also...

Eisai Submits New Dosing Variation for Leqembi Eisai recently announced the submission of a proposed Marketing Authorization Variation to the European Medicines Agency (EMA) for lecanemab, marketed as Leqembi. This initiative aims to establish a maintenance dosing regimen for lecanemab that will allow for intravenous (IV) infusion every four weeks, enhancing the...

Pallet secured an impressive $18 million in Series A funding back in early 2023, aiming to revolutionize the logistics landscape. You know how this game works; cash infusions get the buzz going, and Bain Capital Ventures led this round with notable support from Bessemer Venture Partners and Activant Capital. Adding some flair were angel investors like Zach Frankel and...

Grief Coach University Steps Up After Hurricane Helene In the wake of Hurricane Helene, the need for grief coaching has become critical. Grief Coach University (Grief Coach U) is answering the call by providing essential support for communities facing emotional turmoil. Following the devastation of such disasters, many individuals struggle with their mental health,...

Upcoming Financial Results Announcement from Telos Corporation Telos Corporation (NASDAQ: TLS), known for its cutting-edge cyber, cloud, and enterprise security solutions, has announced it will unveil its financial results for the third quarter. This corporate event is set to take place on a Monday morning, marking an important moment for investors and stakeholders alike....